CYTOSORBENTS CORPORATION
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $9.9M | $8.3M | $3.2M |
| Jun 2017 | $14.2M | $22.1M | $16.4M |
| Sep 2017 | $12.7M | $22.2M | $15.4M |
| Dec 2017 | $13.8M | $24.1M | $17.3M |
| Mar 2018 | $13.9M | $28.3M | $21.1M |
| Jun 2018 | $13.4M | $34.9M | $25.3M |
| Sep 2018 | $14.2M | $34.2M | $24.9M |
| Dec 2018 | $17.3M | $34.2M | $22.4M |
| Mar 2019 | $16.0M | $31.0M | $19.6M |
| Jun 2019 | $16.9M | $28.5M | $16.3M |
| Sep 2019 | $21.9M | $28.7M | $16.0M |
| Dec 2019 | $24.0M | $27.4M | $12.2M |
| Mar 2020 | $22.9M | $44.2M | $26.4M |
| Jun 2020 | $24.9M | $49.3M | $35.1M |
| Sep 2020 | $24.0M | $104.3M | $88.0M |
| Dec 2020 | $10.7M | $90.0M | $71.4M |
| Mar 2021 | $10.2M | $87.5M | $68.5M |
| Jun 2021 | $23.8M | $98.2M | $65.6M |
| Sep 2021 | $24.5M | $95.1M | $61.0M |
| Dec 2021 | $26.9M | $89.5M | $52.1M |
| Mar 2022 | $27.8M | $83.3M | $43.0M |
| Jun 2022 | $23.6M | $71.2M | $30.2M |
| Sep 2022 | $23.1M | $62.3M | $22.6M |
| Dec 2022 | $27.9M | $63.2M | $22.1M |
| Mar 2023 | $27.5M | $57.5M | $19.0M |
| Jun 2023 | $28.0M | $52.4M | $13.2M |
| Sep 2023 | $28.8M | $47.6M | $8.4M |
| Dec 2023 | $29.5M | $53.0M | $14.1M |
| Mar 2024 | $27.4M | $47.1M | $8.6M |
| Jun 2024 | $36.0M | $53.4M | $8.5M |
| Sep 2024 | $34.7M | $47.8M | $5.7M |
| Dec 2024 | $36.3M | $47.4M | $3.3M |
| Mar 2025 | $36.2M | $50.8M | $11.6M |
| Jun 2025 | $36.4M | $48.0M | $10.2M |
| Sep 2025 | $36.7M | $45.8M | $7.5M |
| Dec 2025 | $38.3M | $44.2M | $6.2M |
| Mar 2026 | $38.4M | $40.6M | $4.8M |
| Jun 2026 | $38.7M | $38.0M | $4.4M |